loadpatents
Patent applications and USPTO patent grants for Andrez; Jean-Christophe.The latest application filed is for "benzenesulfonamide compounds and their use as therapeutic agents".
Patent | Date |
---|---|
Benzenesulfonamide compounds and their use as therapeutic agents Grant 11,299,490 - Andrez , et al. April 12, 2 | 2022-04-12 |
Benzenesulfonamide compouds and their use as therapeutic agents Grant 11,174,268 - Andrez , et al. November 16, 2 | 2021-11-16 |
Therapeutic compounds and methods of use thereof Grant 11,149,002 - Andrez , et al. October 19, 2 | 2021-10-19 |
Benzenesulfonamide Compounds And Their Use As Therapeutic Agents App 20210171537 - Andrez; Jean-Christophe ;   et al. | 2021-06-10 |
Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents Grant 10,981,905 - Andrez , et al. April 20, 2 | 2021-04-20 |
Substituted Benzamides And Methods Of Use Thereof App 20210093618 - ANDREZ; Jean-Christophe ;   et al. | 2021-04-01 |
Therapeutic Compounds And Methods Of Use Thereof App 20210078947 - ANDREZ; Jean-Christophe ;   et al. | 2021-03-18 |
Benzenesulfonamide Compounds And Their Use As Therapeutic Agents App 20200354354 - Andrez; Jean-Christophe ;   et al. | 2020-11-12 |
Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors Grant 10,752,623 - Andrez , et al. A | 2020-08-25 |
Benzenesulfonamide compounds and their use as therapeutic agents Grant 10,662,184 - Andrez , et al. | 2020-05-26 |
Heteroaryl-substituted Sulfonamide Compounds And Their Use As Therapeutic Agents App 20200157089 - Andrez; Jean-Christophe ;   et al. | 2020-05-21 |
Substituted Benzamides And Methods Of Use Thereof App 20200108054 - ANDREZ; Jean-Christophe ;   et al. | 2020-04-09 |
Heteroaryl-substituted Sulfonamide Compounds And Their Use As Sodium Channel Inhibitors App 20200071313 - Andrez; Jean-Christophe ;   et al. | 2020-03-05 |
Therapeutic compounds and methods of use thereof Grant 10,526,285 - Andrez , et al. J | 2020-01-07 |
Benzenesulfonamide Compounds And Their Use As Therapeutic Agents App 20190194184 - Andrez; Jean-Christophe ;   et al. | 2019-06-27 |
Benzenesulfonamide compounds and their use as therapeutic agents Grant 10,246,453 - Andrez , et al. | 2019-04-02 |
Therapeutic Compounds And Methods Of Use Thereof App 20190031607 - ANDREZ; Jean-Christophe ;   et al. | 2019-01-31 |
Therapeutic compounds and methods of use thereof Grant 10,125,098 - Andrez , et al. November 13, 2 | 2018-11-13 |
Therapeutic Compounds And Methods Of Use Thereof App 20180265465 - ANDREZ; Jean-Christophe ;   et al. | 2018-09-20 |
Therapeutic compounds and methods of use thereof Grant 10,005,724 - Andrez , et al. June 26, 2 | 2018-06-26 |
Benzenesulfonamide Compounds And Their Use As Therapeutic Agents App 20180162868 - Andrez; Jean-Christophe ;   et al. | 2018-06-14 |
Benzenesulfonamide Compounds And Their Use As Therapeutic Agents App 20170334902 - Andrez; Jean-Christophe ;   et al. | 2017-11-23 |
Therapeutic Compounds And Methods Of Use Thereof App 20170190662 - ANDREZ; Jean-Christophe ;   et al. | 2017-07-06 |
Substituted benzamides and methods of use thereof Grant 9,694,002 - Andrez , et al. July 4, 2 | 2017-07-04 |
Substituted Benzamides And Methods Of Use Thereof App 20170087136 - ANDREZ; Jean-Christophe ;   et al. | 2017-03-30 |
Substituted benzamides and methods of use thereof Grant 9,546,164 - Andrez , et al. January 17, 2 | 2017-01-17 |
N-substituted Benzamides And Methods Of Use Thereof App 20170002017 - Andrez; Jean-Christophe ;   et al. | 2017-01-05 |
Substituted Benzamides And Methods Of Use Thereof App 20150252038 - ANDREZ; Jean-Christophe ;   et al. | 2015-09-10 |
N-substituted benzamides and methods of use thereof Grant 8,952,169 - Andrez , et al. February 10, 2 | 2015-02-10 |
N-substituted Benzamides And Methods Of Use Thereof App 20130317001 - Andrez; Jean-Christophe ;   et al. | 2013-11-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.